892482-36-9

Basic information

• Product Name: 3-chloro-2-(4-methylphenyl)pyridine
• Synonyms: 3-chloro-2-(4-methylphenyl)pyridine
• CAS NO: 892482-36-9
• Molecular Weight: 203.671
• Mol File: 892482-36-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-chloro-2-(4-methylphenyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-2-(4-methylphenyl)pyridine(892482-36-9)
• EPA Substance Registry System: 3-chloro-2-(4-methylphenyl)pyridine(892482-36-9)

Safety Data

• Hazardous Substances Data: 892482-36-9(Hazardous Substances Data)

Upstream product

• 2402-77-9 2,3-dichloro-pyridine 
• 5720-05-8 4-methylphenylboronic acid 
• 5142-75-6 tri(p-tolyl)bismuth 
• 626-60-8 3-Chloropyridine 
• 624-31-7 4-tolyl iodide 
• 937-12-2 4-tolyltrimethylstannane 
• 106-38-7 para-bromotoluene 

Downstream Products

• 892482-73-4 C₁₂H₁₁ClN₂O₂S 
• 847446-86-0 4-(3-chloropyridin-2-yl)benzaldehyde 
• 582325-32-4 4-(3-chloropyridin-2-yl)benzoic acid 

Relevant articles and documents

Cross-coupling study of iodo/chloropyridines and 2-chloroquinoline with atom-economic triarylbismuth reagents under Pd-catalysis

This study describes the palladium-catalyzed couplings of iodopyridines, chloropyridines, and chloroquinoline with atom-economic BiAr3 reagents in sub-stoichiometric loadings. Mono-arylations of iodo and chloropyridines produced arylpyridines i

NOVEL METHOD OF PREPARING BENZOIMIDAZOLE DERIVATIVES

This invention relates to a method of preparing a benzoimidazole derivative at high purity and high yield so as to enable the production of the benzoimidazole derivative compound as an antagonist against a vanilloid reactor-1, and particularly to a method

BENZISOTHIAZOLE-1, 1-DIOXIDE ACTING AS ANTAGONISTS TO THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USES THEREOF

Compounds having formula (I) or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein L, A, G, R1, R2 and R3 are as defined herein. These compounds are particularly useful in the treatment of pain, inflammatory hyperalgesia, and urinary dysfunctions, such as bladder overactivity and urinary incontinence.